Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.65 +0.02 (+2.83%)
At close: Aug 20, 2026 · 2:16 PM UTC

Adagio Medical Holdings (ADGM) Short term Debt (2023)

Adagio Medical Holdings (ADGM) posted Short term Debt of $1.7 million for Q4 2023.

Adagio Medical Holdings (ADGM) Short term Debt (2023) Analysis & Trends

Adagio Medical Holdings has reported Short term Debt for 1 years, with the latest figure at $1.7 million in Q4 2023.

  • Quarterly Short term Debt changed N/A year-over-year to $1.7 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.7 million (changed N/A YoY) and the FY2023 annual result came in at $1.7 million, changed N/A from the prior year.
  • Short term Debt held at $1.7 million in Q4 2023 per ADGM's latest filing.
  • Over five years, Short term Debt peaked at $1.7 million in Q4 2023 and troughed at $1.7 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn
10 Adagio Medical Holdings 14.43 Mn 14.43 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.70 Mn